Last Updated: November 16, 2026

Investigational Drug Information for ALXN1840

« Back to Dashboard


What is the drug development status for ALXN1840?

ALXN1840 is an investigational drug.

There have been 14 clinical trials for ALXN1840. The most recent clinical trial was a Phase 2 trial, which was initiated on October 6th 2021.

The most common disease conditions in clinical trials are Hepatolenticular Degeneration and [disabled in preview]. The leading clinical trial sponsors are Alexion Pharmaceuticals, Wilson Therapeutics AB, and ERT: Clinical Trial Technology Solutions.

There are six US patents protecting this investigational drug and thirty-two international patents.

Recent Clinical Trials for ALXN1840
TitleSponsorPhase
Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson DiseaseAlexion PharmaceuticalsPhase 3
Bioavailability Study of 2 Oral Formulations of ALXN1840Alexion PharmaceuticalsPhase 1
Copper Concentration and Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840Alexion PharmaceuticalsPhase 2

See all ALXN1840 clinical trials

Clinical Trial Summary for ALXN1840

Top disease conditions for ALXN1840
Top clinical trial sponsors for ALXN1840

See all ALXN1840 clinical trials

US Patents for ALXN1840

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ALXN1840 ⤷  Start Trial Bis-choline tetrathiomolybdate for treating Wilson disease Alexion Pharmaceuticals Inc ⤷  Start Trial
ALXN1840 ⤷  Start Trial Thiomolybdate analogues and uses thereof Alexion Pharmaceuticals Inc , University of Michigan Ann Arbor ⤷  Start Trial
ALXN1840 ⤷  Start Trial Shale inhibition additive for oil/gas down hole fluids and methods for making and using same Weatherford Technology Holdings LLC ⤷  Start Trial
ALXN1840 ⤷  Start Trial Shale inhibition additive for oil/gas down hole fluids and methods for making and using same Weatherford Technology Holdings LLC ⤷  Start Trial
ALXN1840 ⤷  Start Trial Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same Weatherford Technology Holdings LLC ⤷  Start Trial
ALXN1840 ⤷  Start Trial Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same Weatherford Technology Holdings LLC ⤷  Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ALXN1840

Drugname Country Document Number Estimated Expiration Related US Patent
ALXN1840 Australia AU2003256704 2022-07-23 ⤷  Start Trial
ALXN1840 Brazil BR0312851 2022-07-23 ⤷  Start Trial
ALXN1840 Canada CA2493127 2022-07-23 ⤷  Start Trial
ALXN1840 China CN100531732 2022-07-23 ⤷  Start Trial
ALXN1840 China CN1684678 2022-07-23 ⤷  Start Trial
ALXN1840 Cyprus CY1114870 2022-07-23 ⤷  Start Trial
ALXN1840 Denmark DK1556029 2022-07-23 ⤷  Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.